Literature DB >> 26861450

Race effects on pathological and functional outcomes after robotic partial nephrectomy in a single academic tertiary care center.

Onder Kara1, Hiury S Andrade2, Homayoun Zargar2, Oktay Akca2, Matthew J Maurice2, Peter A Caputo2, Daniel Ramirez2, Ercan Malkoc2, Charles S Modlin3, Jihad H Kaouk4.   

Abstract

To explore the potential effects of race on pathological outcomes of renal tumor and on kidney function preservation in the patients undergoing robotic partial nephrectomy (RPN) at our center. Retrospective review of our institutional review board approved database for African-American (AA) patients undergoing RPN from 2006 to 2014 was performed. AA and non-AA groups were compared with regards to demographics, tumor characteristics, functional data and, oncological outcomes. For functional outcomes, groups were matched (1:1) in terms of age, preoperative estimated glomerular filtration rate (eGFR) and R.E.N.A.L score. From the total of 1005 patients, 84 were AA. Age and the tumor size were comparable between the two groups (2.7 vs. 3 cm; p = 0.29). Proportion of patients with papillary RCC was higher among AAs compared to non-AAs (43.3 vs. 19.4 %; p < 0.001). After matching AA patients with non-AA counterparts (1:1 matching), eGFR preservation at latest follow up after surgery was comparable between groups (84.3 vs. 85 %; p = 0.25). AA race (OR 3.62, p < 0.001), male gender (OR 2.05, p < 0.001) and low preoperative eGFR (OR 0.97, p < 0.001) were predictors of papillary RCC on multivariate analyses. The incidence of papillary RCC is higher in AA patients undergoing RPN. There was no difference in kidney function recovery after robotic partial nephrectomy in both AA and non-AA groups. AA race itself is not a significant factor in determining renal malignancy. Further studies are needed to clarify the impact of higher prevalence of papillary tumors in AA group in terms of long-term oncological and functional outcomes.

Entities:  

Keywords:  African American; Health disparities; Partial nephrectomy; Race; Robotic

Mesh:

Year:  2016        PMID: 26861450     DOI: 10.1007/s11701-016-0562-3

Source DB:  PubMed          Journal:  J Robot Surg        ISSN: 1863-2483


  28 in total

1.  Culture, race, and disparities in health care.

Authors:  Charles S Modlin
Journal:  Cleve Clin J Med       Date:  2003-04       Impact factor: 2.321

2.  Histological subtype is an independent predictor of outcome for patients with renal cell carcinoma.

Authors:  Bradley C Leibovich; Christine M Lohse; Paul L Crispen; Stephen A Boorjian; R Houston Thompson; Michael L Blute; John C Cheville
Journal:  J Urol       Date:  2010-02-19       Impact factor: 7.450

3.  Racial disparity in renal cell carcinoma patient survival according to demographic and clinical characteristics.

Authors:  Wong-Ho Chow; Brian Shuch; W Marston Linehan; Susan S Devesa
Journal:  Cancer       Date:  2012-11-12       Impact factor: 6.860

4.  Rising incidence of renal cell cancer in the United States.

Authors:  W H Chow; S S Devesa; J L Warren; J F Fraumeni
Journal:  JAMA       Date:  1999-05-05       Impact factor: 56.272

5.  A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group.

Authors:  A S Levey; J P Bosch; J B Lewis; T Greene; N Rogers; D Roth
Journal:  Ann Intern Med       Date:  1999-03-16       Impact factor: 25.391

6.  Rate of renal cell carcinoma subtypes in different races.

Authors:  Alexander Sankin; Jacob Cohen; Hongbei Wang; Richard J Macchia; Nicholas Karanikolas
Journal:  Int Braz J Urol       Date:  2011 Jan-Feb       Impact factor: 1.541

7.  Early onset hereditary papillary renal carcinoma: germline missense mutations in the tyrosine kinase domain of the met proto-oncogene.

Authors:  Laura S Schmidt; Michael L Nickerson; Debora Angeloni; Gladys M Glenn; McClellan M Walther; Paul S Albert; Michelle B Warren; Peter L Choyke; Carlos A Torres-Cabala; Maria J Merino; Joan Brunet; Victòria Bérez; Joan Borràs; Giovanni Sesia; Lindsay Middelton; John L Phillips; Catherine Stolle; Berton Zbar; Stephen E Pautler; W Marston Linehan
Journal:  J Urol       Date:  2004-10       Impact factor: 7.450

8.  Clinicopathological characteristics and outcomes of surgically excised renal masses in African Americans.

Authors:  Peter Qi; Matvey Tsivian; Michael R Abern; Niccolo M Passoni; Kathleen F McGinley; Thomas J Polascik
Journal:  Urol Oncol       Date:  2014-02-02       Impact factor: 3.498

9.  Disparities in treatment and outcome for renal cell cancer among older black and white patients.

Authors:  Sonja I Berndt; H Ballentine Carter; Mark P Schoenberg; Craig J Newschaffer
Journal:  J Clin Oncol       Date:  2007-08-20       Impact factor: 44.544

10.  Cancers of the kidney and urinary tract in patients on dialysis for end-stage renal disease: analysis of data from the United States, Europe, and Australia and New Zealand.

Authors:  John H Stewart; Gherardo Buccianti; Lawrence Agodoa; Ryszard Gellert; Margaret R E McCredie; Albert B Lowenfels; Alex P S Disney; Robert A Wolfe; Peter Boyle; Patrick Maisonneuve
Journal:  J Am Soc Nephrol       Date:  2003-01       Impact factor: 10.121

View more
  2 in total

1.  Prevalence and Characteristics of Patients with Suspected Inherited Renal Cell Cancer: Application of the ACMG/NSGC Genetic Referral Guidelines to Patient Cohorts.

Authors:  Hong Truong; Sarah E Hegarty; Leonard G Gomella; William K Kelly; Edouard J Trabulsi; Costas D Lallas; Veda N Giri
Journal:  J Genet Couns       Date:  2017-01-19       Impact factor: 2.537

2.  Does race impact functional outcomes in patients undergoing robotic partial nephrectomy?

Authors:  Ugo G Falagario; Alberto Martini; John Pfail; Patrick-Julien Treacy; Kennedy E Okhawere; Bheesham D Dayal; John P Sfakianos; Ronney Abaza; Daniel D Eun; Akshay Bhandari; James R Porter; Ashok K Hemal; Ketan K Badani
Journal:  Transl Androl Urol       Date:  2020-04
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.